Tax or exercise withholding
Thomas Trimarchi
President and CFO
Common Stock
- Value context
- $1.82M
- Reported price
- $79.86 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
BridgeBio Pharma, Inc.
Last 30 daysNo qualifying insider buying. Sales: $690.85K by 1 insider.
Showing the first 6 of 20 trades on this page.
President and CFO
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Executive Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Accounting Officer
Common Stock
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| President and CFO | Common StockExercise-price or tax withholding | 22,781$79.86 / share | $1.82M | Aug 16Filed Aug 18 · 2d later | SEC filing |
| Chief Executive Officer | Common StockOption exercise or conversion | 33,544Price not reported | Unavailable | Aug 16Filed Aug 18 · 2d later | SEC filing |
| Chief Executive Officer | Common StockOption exercise or conversion | 19,599Price not reported | Unavailable | Aug 16Filed Aug 18 · 2d later | SEC filing |
| Chief Executive Officer | Common StockOption exercise or conversion | 11,554Price not reported | Unavailable | Aug 16Filed Aug 18 · 2d later | SEC filing |
| Chief Executive Officer | Common StockOption exercise or conversion | 6,520Price not reported | Unavailable | Aug 16Filed Aug 18 · 2d later | SEC filing |
| Chief Executive Officer | Common StockExercise-price or tax withholding | 36,237$79.86 / share | $2.89M | Aug 16Filed Aug 18 · 2d later | SEC filing |
| Chief Executive Officer | Restricted Stock UnitsOption exercise or conversion | Derivative units33,544Exercise / conversion price not reported | Not a separate purchase | Aug 16Filed Aug 18 · 2d later | SEC filing |
| Chief Executive Officer | Restricted Stock UnitsOption exercise or conversion | Derivative units19,599Exercise / conversion price not reported | Not a separate purchase | Aug 16Filed Aug 18 · 2d later | SEC filing |
| Chief Executive Officer | Restricted Stock UnitsOption exercise or conversion | Derivative units11,554Exercise / conversion price not reported | Not a separate purchase | Aug 16Filed Aug 18 · 2d later | SEC filing |
| Chief Executive Officer | Restricted Stock UnitsOption exercise or conversion | Derivative units6,520Exercise / conversion price not reported | Not a separate purchase | Aug 16Filed Aug 18 · 2d later | SEC filing |
| Chief Accounting Officer | Common StockExercise-price or tax withholding | 4,714$79.86 / share | $376.46K | Aug 16Filed Aug 18 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 17,167$16.75 / share | $287.55K | Jul 9Filed Jul 13 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units17,167$16.75 exercise / conversion price | Not a separate purchase | Jul 9Filed Jul 13 · 4d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 19,000$8.45 / share | $160.55K | Jul 9Filed Jul 13 · 4d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 112,422$29.00 / share | $3.26M | Jul 9Filed Jul 13 · 4d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 17,167$16.75 / share | $287.55K | Jul 9Filed Jul 13 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units19,000$8.45 exercise / conversion price | Not a separate purchase | Jul 9Filed Jul 13 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units112,422$29.00 exercise / conversion price | Not a separate purchase | Jul 9Filed Jul 13 · 4d later | SEC filing |
| Director | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units17,167$16.75 exercise / conversion price | Not a separate purchase | Jul 9Filed Jul 13 · 4d later | SEC filing |
| Director | Common StockGrant or award10b5-1 | 3,990Award · no purchase price | Non-cash award | Jun 22Filed Jun 24 · 2d later | SEC filing |
Showing the latest 20 of 67 trades. Show all 67 trades
BridgeBio Pharma, Inc. - Common Stock (BBIO) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberBridgeBio Pharma, Inc. - Common Stock (BBIO) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberBridgeBio Pharma, Inc. - Common Stock (BBIO) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberBridgeBio Pharma, Inc. - Common Stock (BBIO) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberBridgeBio Pharma, Inc. - Common Stock (BBIO) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberBridgeBio Pharma, Inc. - Common Stock (BBIO) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.